Literature DB >> 7910903

Interferon-alpha 2b for refractory ocular Behçet's disease.

E J Feron, A Rothova, P M van Hagen, G S Baarsma, M S Suttorp-Schulten.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7910903     DOI： 10.1016/s0140-6736(94)92549-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  12 in total

Review 1.  Management of sight-threatening uveitis: new therapeutic options.

Authors:  Matthias D Becker; Justine R Smith; Regina Max; Christoph Fiehn
Journal:  Drugs       Date:  2005       Impact factor: 9.546

2.  [Biologics: from the "golden calf" to a "gold standard"?].

Authors:  U Pleyer
Journal:  Ophthalmologe       Date:  2011-03       Impact factor: 1.059

3.  Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients.

Authors:  Bahram Bodaghi; Gael Gendron; Bertrand Wechsler; Céline Terrada; Nathalie Cassoux; Du Le Thi Huong; Claire Lemaitre; Christine Fradeau; Phuc LeHoang; Jean-Charles Piette
Journal:  Br J Ophthalmol       Date:  2006-10-18       Impact factor: 4.638

4.  Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis.

Authors:  I Kötter; M Zierhut; A K Eckstein; R Vonthein; T Ness; I Günaydin; B Grimbacher; S Blaschke; W Meyer-Riemann; H H Peter; N Stübiger
Journal:  Br J Ophthalmol       Date:  2003-04       Impact factor: 4.638

5.  Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study.

Authors:  I Kötter; A K Eckstein; N Stübiger; M Zierhut
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

6.  Clinical Experience of Interferon Alfa-2a Treatment for Refractory Uveitis in Behçet's Disease.

Authors:  Ji-Youn Park; Yoo-Ri Chung; Kihwang Lee; Ji Hun Song; Eun-So Lee
Journal:  Yonsei Med J       Date:  2015-07       Impact factor: 2.759

Review 7.  Review of Systemic Immunosuppression for Autoimmune Uveitis.

Authors:  Claudia Castiblanco; C Stephen Foster
Journal:  Ophthalmol Ther       Date:  2014-03-18

8.  Managing Behçet's disease: An update on current and emerging treatment options.

Authors:  P La van Daele; J H Kappen; P M van Hagen; J Am van Laar
Journal:  Ther Clin Risk Manag       Date:  2009-05-20       Impact factor: 2.423

9.  Interferons and their potential in the treatment of ocular inflammation.

Authors:  Friederike Mackensen; Regina Max; Matthias D Becker
Journal:  Clin Ophthalmol       Date:  2009-10-19

10.  Current trends in the management of ocular symptoms in Adamantiades-Behçet's disease.

Authors:  Fouad R Zakka; Peter Y Chang; Gian P Giuliari; C Stephen Foster
Journal:  Clin Ophthalmol       Date:  2009-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.